Kalkine has a fully transformed New Avatar.

small-cap

Latest with a2 Milk Company Ltd!

Sep 28, 2017 | Team Kalkine
Latest with a2 Milk Company Ltd!

a2 Milk Company Ltd


A2M Details

a2 Milk Company Ltd (Australia) (ASX: A2M) has a commercial relationship with Synlait and had also acquired an 8.2% shareholding in Synlait in March 2017 to boost their relationship with the organization. Recently, the group reported that Synlait has got registration to enable exports of the group’s China label infant formula to China. Primarily, manufacturers of infant formula need to register brands and recipes with the China Food and Drug Administration (CFDA) to import products into China, via traditional import channels, from 1 January 2018. Synlait already submitted the dossier application to the CFDA for the registration of the a2 Milk Company’s infant formula in May 2017.It is worth noting that the group’s relationship with Synlait started in 2010 to manufacture best first infant formula made from milk containing only the A2 beta casein protein type, and free from the A1 protein type. After the huge success and growth, the group made a five-year agreement with Synlait in August 2016. A2M stock rose a little post the above announcement but ended flat on September 28, 2017.

Meanwhile, A2M had delivered gains in revenue and earnings in FY17 based on the outstanding performance in infant formula, and growth in liquid milk in each of its core markets. There has been increased consumer acceptance of the a2™ brand and the benefits of dairy-based products free from the A1 beta casein protein type. 

Strategic Priorities (Source: Company Reports)

However, group’s marketing spend was up owing to building awareness in the US and China. Further, A2M invested on patents, trademarks, and research and development, and business expansion activities. A2M now expects marketing spend for 1H18 to be ~NZ$5 million higher than 2H17.

The shares of A2M generated outstanding returns of 196.53% this year (as of September 27, 2017) placing the stock at higher levels; and the same now look touch “Expensive” at the current price of $ 5.99


A2M Daily Chart (Source: Thomson Reuters)


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.